These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6324812)

  • 81. Radioreceptor and high-performance liquid chromatographic assays for the calcium channel antagonist nitrendipine in serum.
    Janis RA; Krol GJ; Noe AJ; Pan M
    J Clin Pharmacol; 1983 Jul; 23(7):266-73. PubMed ID: 6886028
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Stimulation of prostacyclin production in blood vessels by the antithrombotic drug suloctidil.
    Boeynaems JM; Van Coevorden A; Demolle D
    Biochem Pharmacol; 1987 May; 36(10):1629-35. PubMed ID: 3036152
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of the antithrombotic drug suloctidil on low density lipoprotein processing and cholesterol metabolism in cultured human fibroblasts.
    Mazière C; Mazière JC; Houtia NE; Lauga J; Polonovski J
    J Clin Chem Clin Biochem; 1988 Jan; 26(1):3-6. PubMed ID: 2836546
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Suloctidil-phospholipid interaction in bilayer membranes: effects on lipid dynamics.
    Chatelain P; Ruysschaert JM
    Biochem Pharmacol; 1981 Feb; 30(4):313-7. PubMed ID: 6260117
    [No Abstract]   [Full Text] [Related]  

  • 85. Antithrombotic activity of suloctidil.
    Roba J; Defreyn G; Biagi G
    Thromb Res Suppl; 1983; 4():53-8. PubMed ID: 6314585
    [No Abstract]   [Full Text] [Related]  

  • 86. Quinidine-induced potentiation of cardiovascular effects of nitrendipine: functional aspects and possible molecular mechanisms.
    Herzig S; Jischa J; Beinhauer A; Geirhos B; Tacke K; Hempelmann RG
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):636-43. PubMed ID: 7675123
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
    Gubin J; de Vogelaer H; Inion H; Houben C; Lucchetti J; Mahaux J; Rosseels G; Peiren M; Clinet M; Polster P
    J Med Chem; 1993 May; 36(10):1425-33. PubMed ID: 8496910
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as drug for the elderly.
    Montefusco O; Missale C; Govoni S; Rozzini R; Trabucchi M
    Pharmacol Res Commun; 1983 Mar; 15(3):317-27. PubMed ID: 6304786
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Antigenicity of suloctidil].
    Takahashi K; Arai Y
    J Toxicol Sci; 1983 Aug; 8(3):231-42. PubMed ID: 6319726
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The heterogeneity of the slow channel blockers (calcium antagonists).
    Nayler WG
    Int J Cardiol; 1983 Jul; 3(4):391-400. PubMed ID: 6350195
    [No Abstract]   [Full Text] [Related]  

  • 91. Distribution of 3H-nitrendipine in the isolated perfused rat heart as revealed by electron microscopic autoradiography.
    Ashraf M; Park WH; Grupp I; Schwartz A
    J Mol Cell Cardiol; 1986 Mar; 18(3):265-72. PubMed ID: 2937925
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Plasma viscosity: relation to age, atherogenic diet and suloctidil.
    Amico-Roxas M; Drago F; Canonico PL; Russo A; Terranova R; Spitaleri A; Bianchi A
    Pharmacol Res Commun; 1981 Sep; 13(8):765-7. PubMed ID: 6270707
    [No Abstract]   [Full Text] [Related]  

  • 93. Effect of suloctidil on blood viscosity in healthy volunteers after forearm occlusion.
    Drago F; Canonico PL; Amico-Roxas M
    Experientia; 1981 Oct; 37(10):1095-6. PubMed ID: 6273209
    [No Abstract]   [Full Text] [Related]  

  • 94. 1H-NMR study of suloctidil-A23187 calcium ionophore interaction.
    Chauvet-Monges AM; Faure R; Crevat A
    Chem Biol Interact; 1993 Feb; 86(2):163-9. PubMed ID: 8383582
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of calcium in gamma interferon induction: inhibition by calcium entry blockers.
    Dianzani F; Capobianchi MR; Facchini J
    J Virol; 1984 Jun; 50(3):964-5. PubMed ID: 6427475
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Conformational analysis of suloctidil and derivatives inserted in lipid layers.
    Brasseur R; Ruysschaert JM; Chatelain P
    Biochem Pharmacol; 1984 Apr; 33(7):1015-21. PubMed ID: 6324809
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Suloctidil: relationship between pharmacokinetics and antithrombotic effect.
    Roba J; Cavalier R; Herin M; Lambelin G
    Thromb Res Suppl; 1983; 4():113-8. PubMed ID: 6314584
    [No Abstract]   [Full Text] [Related]  

  • 98. Suloctidil hepatitis: a case presentation.
    Kelly CP; England RE; McDonald GS; Weir DG
    Ir J Med Sci; 1987 Oct; 156(10):290-1. PubMed ID: 2828270
    [No Abstract]   [Full Text] [Related]  

  • 99. Elevated liver enzymes in serum during suloctidil treatment.
    Schouten JA; Westerman RF
    Eur J Clin Pharmacol; 1982; 22(6):559-60. PubMed ID: 6290229
    [No Abstract]   [Full Text] [Related]  

  • 100. Photodegradation of nifedipine relative to nitrendipine evaluated by liquid and gas chromatography.
    Logan BK; Patrick KS
    J Chromatogr; 1990 Jul; 529(1):175-81. PubMed ID: 2211929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.